Abstract: The present invention is related to glucocorticoid receptor agonists comprised of a compound represented by formula (1) which is 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative or a salt thereof and novel pharmacological effects of the glucocorticoid receptor agonists. In the formula (1), R1 represents formula (2a), (3a), (4a) or (5a); R2 represents —(CO)—R8, —(CO)O—R9, or the like; R2—O— is substituted at the 4- or -5-position of benzene ring A; R3 represents a lower alkyl group; R4, R5, R6 or R7 represents a halogen atom, a lower alkyl group which may have a substituent, or the like; m, n, p or q represents 0, 1 or the like; R8, R9 or the like represents a lower alkyl group which may have a substituent, a lower alkenyl group, or the like.

Abstract: An electrode dryer includes a drying furnace; and a conveyance member for longitudinally conveying a band-like electrode base material coated with a coating material from an entrance to an exit of the drying furnace, the drying furnace including an air-permeable mounting member for horizontally supporting the electrode base material to be conveyed in the drying furnace; and a suction member for sucking the electrode base material through the air-permeable mounting member.

Abstract: An electrode for a nonaqueous electrolyte secondary battery includes a current collector and an electrode material disposed on the current collector. the electrode material has a thickness of 50 ?m or larger. The electrode material contains at least active material particles, an electro-conductive material, and a crack preventive material. An average particle diameter of the crack preventive material is two times or larger than an average particle diameter of the active material particles.

Abstract: The aqueous paste for an electrochemical cell of the present invention comprises an aqueous dispersion for an electrochemical cell that comprises an olefin copolymer (a); an active material; and a conductive assistant, wherein the olefin copolymer (a) has a weight average molecular weight of not less than 50,000 and is at least one kind selected from a random propylene copolymer (a-1) containing 50% by weight to less than 85% by weight of a structural unit derived from propylene; an acid-modified random propylene copolymer (a-2) obtained by modifying the copolymer (a-1) with an acid; and an ethylene-(meth) acrylic acid copolymer (a-3) containing 5% by weight to less than 25% by weight of a structural unit derived from (meth) acrylic acid.

Abstract: A non-aqueous electrolyte secondary battery comprising electrodes including a positive electrode and a negative electrode, a separator positioned between the electrodes, and a non-aqueous electrolyte, wherein the electrodes have a collector carrying an active substance material, and the collector of at least one of the positive electrode and the negative electrode is a three-dimensional structure formed of a resin fiber covered with a metal film.

Abstract: The object aims to find a novel pharmacological activity of a novel 1,2,3,4-tetrahydroquinoxaline derivative which contains, as a substituent, a phenyl group having a sulfonic acid ester structure introduced therein. A compound represented by general formula (1) or a salt thereof is useful as a glucocorticoid receptor agonist, particularly as a therapeutic agent for diseases against which a glucocorticoid receptor agonist (e.g., a steroid) is believed to be effective, such as inflammatory bone/joint diseases, inflammatory ophthalmic diseases (inflammatory ophthalmic diseases in the anterior or posterior segment of an eye).

Abstract: A charging control method for a non-aqueous electrolyte secondary cell is a charging control method for controlling a state of charge of a non-aqueous electrolyte secondary cell that has a non-aqueous electrolyte between electrodes, a target state of charge serving as a target for stopping charging is preset in correspondence with an ambient temperature of the non-aqueous electrolyte secondary cell, and the target state of charge (e.g., 95%) for when the ambient temperature is a specific temperature (e.g., 25° C. or 20° C. to 30° C.) that has been specified in advance is set higher compared to the target state of charge for a temperature other than the specific temperature.

Abstract: The present invention is related to glucocorticoid receptor agonists comprised of a compound represented by formula (1) which is 2,2,4-trimethyl-6-phenyl-1,2-dihydroquinoline derivative or a salt thereof and novel pharmacological effects of the glucocorticoid receptor agonists. In the formula (1), R1 represents formula (2a), (3a), (4a) or (5a); R2 represents —(CO)—R8, —(CO)O—R9, or the like; R2—O— is substituted at the 4- or -5-position of benzene ring A; R3 represents a lower alkyl group; R4, R5, R6 or R7 represents a halogen atom, a lower alkyl group which may have a substituent, or the like; m, n, p or q represents 0, 1 or the like; R8, R9 or the like represents a lower alkyl group which may have a substituent, a lower alkenyl group, or the like.

Abstract: According to the present invention, a powdery preparation for nasal administration comprising a physiologically active substance, a non-water-absorbing and hardly water-soluble powder(s) and one or two selected from the group consisting of a mucolytic agent and a nonionic surfactant is provided.

Abstract: According to the present invention, a powdery preparation for nasal administration comprising a physiologically active substance, a non-water-absorbing and hardly water-soluble powder(s) and one or two selected from the group consisting of a mucolytic agent and a nonionic surfactant is provided.